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INTRODUCTION
Collagens are triple-helical molecules that form the major structural
elements of almost all tissues outside the nervous system. Collagen
types I, II and III are evolutionarily related, and comprise the
quantitatively major fibril-forming (fibrillar) collagens (Olsen,
1991). They form organotypic matrices by tissue-specific expression
and by assembly of the collagen triple-helix into a variety of
supramolecular aggregates (Birk et al., 1991). Collagen I is the
major extracellular matrix (ECM) protein of bone, tendons,
ligaments, and the dermis of the skin. Collagen II is the major
collagen of cartilage, but it is also present in the vitreous of the eye
and in the nucleus pulposus of the intervertebral disc (Zhu et al.,
1999). Collagen III is a component of many stretchable tissues, such
as the vascular wall, dermis, lung, heart and gastrointestinal tract (De
Paepe and Malfait, 2004). It can co-polymerize with collagen I to
form heterotypic fibrils and it is co-expressed in varying proportions
with collagen I at many locations, with the exception of bone
(Niederreither et al., 1995). Collagen I contains two 1(I) chains and
one 2(I) chain, whereas collagens II and III are homotrimers of
1(II) and 1(III) chains, respectively (Olsen, 1991). Structural
mutations in collagen genes have serious consequences for tissues
where single collagen types are major constituents. Collagen I
mutations cause osteogenesis imperfecta (Rauch and Glorieux,
2004). Chondrodysplasias, sometimes with ocular anomalies, such
as Stickler syndrome, are caused by collagen II mutations (Chan et
al., 1995; Cole, 1997; Snead and Yates, 1999; Tiller et al., 1995), and
collagen III mutations cause the vascular subtype of the Ehlers-
Danlos syndrome (type IV), which is characterized by aortic
aneurysms and skin fragility (De Paepe and Malfait, 2004).
Fibrillar collagens are made as a precursor (procollagen) and
consist of a long triple-helical (collagenous) domain flanked at each
end by globular non-collagenous propeptides (Olsen, 1991). The
three major fibrillar procollagens share similar biosynthetic
mechanisms. Following intracellular assembly of the triple helix, the
procollagen molecules undergo proteolytic excision of each
propeptide either prior to or following secretion (Canty et al., 2004;
Olsen, 1991). The C-propeptide is excised by BMP1, an astacin-like
protease (Kessler et al., 1996). ADAMTS2 (for A Disintegrin-like
And Metalloprotease domain with Thrombospondin type 1 motifs
2) can excise the N-propeptide of all three major fibrillar collagens
(Tuderman and Prockop, 1982; Wang et al., 2003). The processed
collagen monomers assemble into fibrils and tissue-specific
supramolecular aggregates. Because of a common biosynthetic
pathway, it was expected that defects in ADAMTS2 would have
broader effects than structural mutations involving individual
procollagen chains. Instead, ADAMTS2 mutations lead to a limited
clinical syndrome – dermatosparaxis (fragility of skin) in animals
and the Ehlers-Danlos syndrome-type VIIC (EDS-VIIC or the
dermatosparactic type) in humans (Colige et al., 2004; Colige et al.,
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1999; Lapiere and Nusgens, 1993; Nusgens et al., 1992; Petty et al.,
1993; Smith et al., 1992; Wertelecki et al., 1992). Collagen fibrils in
the dermis of dermatosparactic calves, humans and mice are thin,
branched and ‘hieroglyphic’ on cross-section, instead of being round
and of relatively uniform diameter (Li et al., 2001; Nusgens et al.,
1992). Although this disorder is largely caused by anomalies in skin
(dermal) collagen, there is only a modest effect on other collagen I-
rich tissues, such as bone, tendon and muscle (Lapiere and Nusgens,
1993). Processing of procollagen II in the cartilage of
dermatosparactic calves and mice is only minimally compromised,
or not at all (Fernandes et al., 2001; Li et al., 2001).
It was hypothesized that enzymes closely related to ADAMTS2
may process procollagen I in tissues other than skin (Lapiere and
Nusgens, 1993); this is supported by the observation that in bovine
dermatosparaxis, the residual processed procollagen is cleaved at the
expected site (Colige et al., 2002). We previously found that
ADAMTS3, could process the amino-propeptide of procollagen II
(Fernandes et al., 2001). Subsequently, it was shown that another
homologous enzyme, ADAMTS14, could process procollagen I
(Colige et al., 2002), and that ADAMTS2 could process procollagen
III (Wang et al., 2003). Nevertheless, a comprehensive
understanding of how these enzymes participate in collagen
biosynthesis in vivo, particularly during embryogenesis, as the first
collagenous matrices are laid down, has not been achieved.
ADAMTS2, ADAMTS3 and ADAMTS14 constitute an
evolutionarily related cluster of ADAMTS proteases, the
procollagen amino-propeptidases (PNPs). They have an identical
domain structure and a unique modular composition not present in
any other enzyme. The active site sequence in their catalytic domain
(HETGHVLGMEHD) differs from that of the other ADAMTS
proteases. This, and previous experimental evidence, suggested that
their catalytic activities are very similar (Colige et al., 2002;
Fernandes et al., 2001; Wang et al., 2003). Here, we demonstrate,
through the temporal and spatial analysis of mRNA encoding
ADAMTS2, ADAMTS3 and ADAMTS14, as well as of that
encoding procollagen I, II and III, that there is highly coordinated
developmental expression of two of these enzymes and their
procollagen substrates during mouse embryogenesis. We
demonstrate that ADAMTS3 can process procollagen I. Together
with its prominent expression in some procollagen I rich tissues and
in cartilage, ADAMTS3, and not ADAMTS2, may be the major
procollagen I and II aminopropeptidase from a developmental
perspective. ADAMTS2 is essential for procollagen III processing




cDNA clones suitable for in vitro transcription of mouse pro-1(I)
collagen (Col1a1) and mouse pro-1(III) collagen (Col3a1) were provided
by E. Vuorio (University of Turku, Finland) (Niederreither et al., 1995).
The mouse pro-1(II) collagen (Col2a1) cDNA was provided by Dr
Naomi Fukai (Harvard Medical School). The Adamts2 probe was
generated by subcloning a 600 base pair (bp) NotI-PstI fragment from
IMAGE clone AA832579 into pBluescript II (Stratagene, La Jolla, CA).
The following primers were used to amplify Adamts3 and Adamts14
cDNA fragments by RT-PCR of mouse 17.5 days post-coitum (dpc)
embryo cDNA.
Adamts3 (amplifying a 528 bp fragment corresponding to the unique C-
terminal domain of mouse Adamts3), 5-CTGAAGAGCTGGTCTCAGTG-
3 (forward) and 5-TGGACTTGTCACCCAAACATG-3 (reverse); and 
Adamts14 (producing a PCR product of 310 bp that corresponds to the
unique C-terminal domain), 5-AGGTGGGTGACAGAAGAGTGG-3
(forward) and 5-AGGCTGCAGATCTGCACCATG-3 (reverse).
The PCR products were cloned into pGEMT-Easy (Promega, Madison,
WI). Radioactive sense and antisense cRNA probes were generated by in
vitro transcription using T3, T7 or SP6 RNA polymerases in the presence of
[35S]-UTP (Perkin-Elmer).
In situ hybridization
In situ hybridization was performed on tissue sections of mouse embryos of
gestational age 7.5 to 17.5 dpc. Embryos, including the surrounding uterus
at 7.5 dpc and 9.5 dpc, were fixed overnight in 4% paraformaldehyde,
embedded in paraffin wax, and sectioned at 6 m. The sections were
hybridized to [35S]-UTP labeled riboprobes, as previously described
(Somerville et al., 2003). Slides were dipped in NTB-2 emulsion (Kodak,
Rochester, NY) and exposed at 4°C for 2 to 10 days. Nuclei were stained
with Hoechst 33258 (Sigma, St Louis, MO). Dark-field (autoradiographic
signal) and fluorescence microscopy (nuclear staining) images were
captured on a Leica DMR upright microscope (Leica Microsystems, Wetzlar
GmbH), with a Retiga Exi Fast 1394 cooled CCD camera with RGB liquid
crystal color filter slider (Q Imaging, Burnaby, BC, Canada). Images were
viewed with ImagePro Plus software (Media Cybernetics, Silver Spring,
MD). Silver grains visualized on dark field microscopy were given a red
pseudocolor and superimposed on nuclear fluorescence (blue).
ADAMTS3 antibodies
A polyclonal antibody was generated in rabbits by immunization with a C-
terminal peptide from human ADAMTS3 (CKKDGKIIDNRRPTRSSTLER-
COOH), coupled to keyhole-limpet hemocyanin (Alpha Diagnostics
International, Houston, TX). The antiserum was affinity-purified against the
peptide coupled to NHS-sulfolink (Pierce).
Cloning of cells expressing ADAMTS3 and co-culture with
dermatosparactic ﬁbroblasts
HEK 293F cells (Invitrogen, Carslbad, CA) were maintained in growth
medium (DMEM supplemented with antibiotics and 10% fetal bovine
serum). Clones stably expressing the ADAMTS3 expression plasmid
pSHTS3 were isolated as previously described (Fernandes et al., 2001).
Culture media were analyzed by western blotting with ADAMTS3
polyclonal antibody at a 1:1000 dilution, and clones expressing the highest
levels of ADAMTS3 were used in subsequent studies. Peptide N-
glycosidase F (PNGaseF, New England Biolabs, Beverly, MA) treatment of
conditioned medium was carried out as previously described (Somerville et
al., 2003). Dermatosparactic calf fibroblasts were cultured alone or co-
cultured with equivalent numbers of HEK293 cells transfected with the
empty plasmid vector (a negative control), or with the plasmid vector
expressing either ADAMTS3 or ADAMTS2 (as a positive control) (Colige
et al., 2002). Co-culture experiments were performed in DMEM
supplemented with 2% FCS and ascorbic acid (50 g/ml) in the absence of
G418. After 24 hours, the culture medium and the cell layer were collected
separately and denatured in Laemmli sample buffer with or without 0.1 M
DTT. The characterization of collagen polypeptides was performed by
western blotting using type I or type III collagen-specific antiserum and
ECL. These antisera were produced by repeated immunization of rabbit and
guinea pig with bovine collagen I or collagen III, respectively. These
antisera, used at a 1:2000 dilution, were highly specific and did not cross-
react with other collagen types (data not shown).
Histology, transmission electron microscopy (TEM) and mCT of
Adamts2-deﬁcient (Adamts2–/–) mice
Adamts2–/– mice in the 129Sv strain were kindly provided by D. Prockop
(Tulane University) and were used under approved institutional protocols.
Genotype analysis was by PCR as previously described. Two-month-old
mice were killed by CO2 inhalation, and tissues and organs were isolated for
histological analysis and for transmission electron microscopy. Lungs were
fixed in 10% formalin under inflation as previously described (Oblander et
al., 2005), followed by routine histology, including Hematoxylin and Eosin
stain, Hart’s stain for elastin and the Mallory trichrome stain. The skulls and
hind limbs of the Adamts2–/– mice and wild-type littermates were analyzed
by micro-computerized tomography (mCT), followed by three-dimensional
reconstruction of the images. Samples for TEM were prepared as previously
described (Birk and Trelstad, 1986). Thick sections (1 m) were cut and











stained with methylene blue-azure B. Thin sections were cut using a Leica
UCT ultramicrotome and a diamond knife. The lung was stained with 2.5%
(w/v) ethanolic uranyl acetate followed by 0.04% (w/v) bismuth subnitrate.
The aorta was stained with aqueous 2% (w/v) uranyl acetate followed by
lead citrate. Sections were examined and photographed at 80 kV using a
Tecnai 12 transmission electron microscope equipped with a Gatan US1000
2K Ultrascan digital camera.
Procollagen processing in Adamts2–/– mice
Individual organs were isolated from Adamts2–/– mice and wild-type
littermates. These were either ground in liquid nitrogen and suspended in
washing buffer [0.25 M sucrose, 20 mM EDTA, 2.5 mM NEM, 0.5 mM
PMSF, 50 mM Tris (pH 7.5)] or directly solubilized in Laemmli sample
buffer (aorta). After centrifugation (20000 g, 10 minutes), supernatants were
discarded and pellets washed again as described above. Pellets were then
suspended in 0.15 M extraction buffer [0.15 M NaCl, 50 mM Tris (pH 7.5)],
rotated for 2 hours at 4°C and centrifuged (20000 g, 10 minutes). Extracts
were collected and pellets sequentially extracted in 1 M extraction buffer [1
M NaCl, 50 mM Tris (pH 7.5)] and 0.1 M acetic acid. Adequate amounts of
the various samples were then dialyzed at 4°C in 0.1 M acetic acid,
lyophilized, denatured in Laemmli sample buffer with or without 0.1 DTT,
and analyzed by SDS-PAGE. Sponge granulomas were induced by the
subcutaneous insertion of circular PVA sponges (10 mm diameter, clinical
PVA sponges grade 3, M-PACT Worldwide Management, Eudora, KS) re-
hydrated in PBS. After 4 weeks, mice were sacrificed and sponges were
collected. Histology demonstrated the presence of abundant granulation
tissue containing fibroblasts and blood vessels (data not shown). The
sponges were ground, washed as described above, and then proteins were
extracted in Laemmli sample buffer, separated by SDS-PAGE and western
blotted with anti-collagen III as described above.
RESULTS
The distribution of the fibrillar collagen mRNA was consistent with
previous reports (Niederreither et al., 1995). Thus, Col1a1 was
primarily expressed in bone, skin, perichondrium, periosteum,
tendons and the adventitia (outermost layer) of blood vessels.
Col2a1 was expressed almost exclusively in cartilage. Col3a1
expression was prominent in the vascular wall, lung mesenchyme,
peritoneal lining and the wall of visceral organs. Col3a1 was co-
expressed with Col1a1 in skin, but not in bone. None of the sense
probes for any of the collagen or ADAMTS genes gave a signal
above background levels.
Adamts2 and Adamts3 are expressed in the
maternal tissues at day 7.5 of gestation
Northern analysis of commercial embryo RNA blots had shown the
highest expression of both Adamts2 and Adamts3 at 7 dpc
(Fernandes et al., 2001). However, in situ hybridization clarified that
there was no expression in the embryo itself, whereas there was
strong expression in maternal tissues, specifically in the decidual
reaction and the myometrium of the uterus. Prominent Col1a1
expression was seen in these tissues. Col1a1 and Adamts3
expression overlapped significantly in the decidual reaction (Fig. 1).
The Adamts2 expression pattern was different, but also overlapped
with Col1a1 (Fig. 1). The prominent co-expression of Col1a1 with
these biosynthetic enzymes reflects the intense remodeling of the
uterus that occurs during pregnancy. These data suggest that the
previously described northern analysis findings resulted from the
inclusion of a significant amount of maternal tissue.
Adamts3, but not Adamts2 or Adamts14, is co-
expressed with Col2a1 in cartilage
Most of the skeleton is formed from cartilage models that undergo
endochondral ossification. Cartilage is first formed around 12 dpc in
mesenchymal condensations that begin to express procollagen II and
aggrecan. We have previously shown that ADAMTS3 processed
procollagen II in vitro, and that ADAMTS3 mRNA was present at
higher levels than ADAMTS2 mRNA in cultured chondrocytes by
RT-PCR (Fernandes et al., 2001). However, in that study, the spatial
and temporal association of Adamts3 and Col2a1 was not
determined. Adamts3 mRNA was associated with Col2a1 mRNA
expression from the initiation of chondrogenesis (Fig. 2A) and,
subsequently, throughout skeletal development in all cartilage
models, whether in the appendicular, axial or craniofacial skeleton
(Fig. 2A-G). Chondrocytes in developing growth plates differentiate
into hypertrophic chondrocytes and, as they do so, they suppress
collagen II production and produce an abundance of a short-chain
collagen, type X (LuValle et al., 1989), whose N-propeptides are not
processed. Interestingly, Adamts3 was downregulated as
chondrocytes became hypertrophic (Fig. 2C,E-G). After 12 dpc, pre-
cartilaginous mesenchymal tissue is located in the perichondrium
around cartilage (Zhu et al., 1999); The Adamts3 expression domain
extended beyond the limits of the Col2a1 expression domain into the
perichondrium (Fig. 2B-G). Neither Adamts2 nor Adamts14 were
detectable by in situ hybridization in cartilage at any developmental
stage examined.
Adamts3, but not Adamts2 or Adamts14, is co-
expressed with Col1a1 during bone and
musculotendinous development
During endochondral ossification, as well as during intra-
membrane ossification, osteoblasts deposit collagen I in the
osteoid, which is subsequently mineralized to form bone. During
both types of osteogenic processes, Adamts3 was co-expressed
with Col1a1 (Fig. 3A,B). In addition, Adamts3 was co-expressed
with Col1a1 in perichondrium, including that around the
hypertrophic zone of cartilage (Fig. 2C, Fig. 3A,C).
Musculotendinous structures develop around the skeleton and
synthesize abundant collagen I late in development; Adamts3 was
expressed in these structures at many locations in the skeleton at
17.5 dpc (Fig. 2D,E, Fig. 3B-D). Neither Adamts2 nor Adamts14
were detectable by in situ hybridization in bone or
musculotendinous tissue during embryonic development.
Adamts2–/– mice have a normal skeleton and teeth
mCT analysis of two-month-old mice in whom skeletal maturity was
attained, demonstrated no consistent anomalies in either the
appendicular, axial or craniofacial skeleton. The overall morphology
of the skull, as well as the surface features such as vascular foramina
and the dimensions of its component bones, appeared no different
from that of wild-type littermates (Fig. 4A). Severe abnormalities of
the secondary dentition have been documented in EDS-VIIC
patients (De Coster et al., 2003; Malfait et al., 2004). Incisors from
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Fig. 1. Adamts2 and Adamts3 expression overlap with Col1a1 in
the 7.5 dpc uterus. Note that Adamts3 expression is similar to that of
Col1a1, whereas Adamts2 expression is different but has partial
overlap. Asterisk indicates the embryo, which did not show expression.












Adamts2–/– mice appeared normal, although molar teeth from
Adamts2–/– mice showed a subtle loss of surface contour when
compared with the wild-type littermates (Fig. 4A). Although
Adamts2 expression was not detectable during tooth development,
Adamts3, but not Adamts14, was highly expressed in the dental
papilla and at lower levels in ameloblasts (Fig. 4B).
ADAMTS3 rescues a procollagen I processing
defect in dermatosparactic skin ﬁbroblasts
HEK293F cells stably transfected with an ADAMTS3 expression
plasmid, but not vector-transfected cells, produced an ~130-150 kDa
protein that was reactive with the affinity-purified ADAMTS3
antibodies. The reactive band migrated faster after digestion with
PNGase F as expected, since ADAMTS3 is predicted to have a N-
linked carbohydrate (Fig. 4C). Type I collagen produced by
dermatosparactic calf skin fibroblasts (DS) in culture consists of pro
1(I) and pro 2(I) in the cell layer, and pro 1(I), pro 2(I) and
pN1(I) in the medium, demonstrating the absence of significant
type I aminoprocollagen peptidase activity (Fig. 4D). In co-culture
with control HEK293F transfected cells (Ct), pro 1(I) and pro 2(I)
are also the most abundant products, but pC1(I), pN1(I), 1(I)
and pN2(I) are also detected, especially in the conditioned
medium. These data illustrate the presence of low amino- and
carboxy-procollagen peptidase activity. This is probably related to
the synthesis of low levels of BMP1, ADAMTS3 and/or
ADAMTS14 by DS, enzymes that may be more active in the high-
confluence conditions observed in co-cultures than in monocultures.
HEK293F cells expressing ADAMTS2 were used as a positive
control. When co-cultured with DS, fully processed 1(I) and 2(I),
and a significant amount of pC1(I), were found associated with the
cell layer. In the conditioned medium, only collagen molecules fully
processed at the N terminus [1(I), 2(I), pC1(I) and pC2(I)]
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Fig. 2. Co-expression of Adamts3 and Col2a1 in
musculoskeletal tissues. (A-G) In situ hybridization is
used to show expression of Adamts3 in developing
cartilage from 12.5 dpc to 17.5 dpc. In A-D, images
include hybridization of Col2a1 to adjacent serial sections.
Hoechst 33258 stained images are included on the far
right for morphological correlation; the age of the embryo
from which the section was taken is shown on the right.
(A) Expression in initial sites of chondrogenesis in the
developing ribs (arrows). (B) Expression in primordial
cartilage of the ankle joint. T, tibia; Ts, Talus; C, calcaneus.
(C) Expression in the proximal humerus growth plate. Note
that expression is restricted to the proliferating zone (PZ).
Hypertrophic zone chondrocytes (HZ) do not express
Adamts3. Col2a1 is not expressed in the bone of the
primary ossiﬁcation center (B). Adamts3 is expressed in the
perichondrium (arrow) and bone. (D) Proximal femur. The
arrow indicates a tendon insertion site where Adamts3,
but not Col2a1 is expressed. (E-G) 17.5 dpc skeletal
elements, demonstrating that Adamts3 is not expressed by
hypertrophic chondrocytes. (E) Absence of Adamts3
expression in the hypertrophic chondrocytes (HC) of the
manubrium sterni. Note Adamts3 expression in developing
intercostal muscle (arrow). (F) Ribs and vertebral lateral
process. The rib elements contain hypertrophic
chondrocytes (asterisk) that do not express Adamts3. By
contrast, the lateral process of a thoracic vertebra (v) has
small chondrocytes and these express Adamts3. The black
oval indicates a spurious signal from erythrocytes.
(G) Sagittal section through the basi-occiput (BO) and the
dens (d) of the second cervical vertebra. Note the strong
expression of Adamts3 in regions containing small
chondrocytes and absence from the hypertrophic zone
(asterisk). Expression is seen in the perichondrium (arrows).












Fig. 3. Co-expression of Adamts3 and Col1a1 in the
musculoskeletal system. All images are from 15.5 and 17.5
dpc embryos; Hoechst 33258-stained images are shown in the
right-hand panel. (A) Expression in the appendicular skeleton
(proximal humerus). Note that Adamts3 expression overlaps
with Col1a1 in bone (B) and in the perichondrium around the
hypertrophic zone and the periosteum (around bone).
Chondrocytes in the proliferating zone (PZ) and hypertrophic
zone (HZ) are indicated; arrows indicate mRNA in muscle.
(B) Expression in the craniofacial skeleton. Note co-expression
of Col1a1 and Adamts3 in bone (B) in the mandible and
maxilla, as well as in developing masseter muscle (mt).
(C) Expression in the proximal femur. The trochanteric fossa
(TF), which contains the obturator tendons, is indicated by the
arrow. The left panel in this ﬁgure is the same as that in
Fig. 2D. (D) Expression in the developing Achilles tendon at
15.5 dpc. The image on the left shows Adamts3 expression in
the ankle cartilage (C) and tendon (arrow); that on the right
shows the Achilles tendon at a higher magniﬁcation (boxed
area in middle panel). Scale bar: 100 m.
Fig. 4. Adamts3, not Adamts2,
has a role in procollagen I
processing in the skeleton.
(A) Normal craniofacial
development, bone structure and
minimal tooth involvement in
Adamts2–/– mice. mCT analysis and
three-dimensional reconstruction of
skulls of Adamts2–/– mice and wild-
type (+/+) littermates do not show
differences in overall patterning,
size, dimensions or organization of
any craniofacial elements. The
lower panels show tooth
morphology from littermates. Note
the poorly deﬁned topography of
molars from Adamts2–/– mice,
although the overall morphology is
similar. (B) Adamts3, but not
Adamts2 or Adamts14, was
strongly expressed during tooth
development in the dental papilla
(DP), and was expressed less
strongly in the ameloblasts (arrow).
(C) Expression of ADAMTS3 in
stably transfected 293 cells.
Conditioned medium from cells was analyzed by western blotting with a polyclonal antibody to ADAMTS3. Note that upon treatment with PNGase
F, ADAMTS3 migrates faster. Untransfected cells showed no protein. Molecular mass markers are indicated on the right. (D) Rescue of the
procollagen I processing defect by ADAMTS2 and ADAMTS3 in dermatosparactic calf skin ﬁbroblasts (DS). DS were plated alone or mixed with an
identical number of HEK-293 cells stably transfected with an empty expression vector (Ct), or with the same vector encoding ADAMTS2 (TS2) or
ADAMTS3 (TS3). After two days in culture, western blotting of a non-reducing SDS-PAGE gel was used to detect type I collagen. Note that the
antibody used detects both 1 and 2 chains, but reacts more strongly with the 1 chain. The identity of collagen polypeptides associated with the
cell layer or recovered from the conditioned culture medium is indicated between the two panels. (E) Rescue of the procollagen III processing defect
by ADAMTS2 and ADAMTS3 in DS. Samples used in D were also analyzed by western blotting using an anti-collagen III antiserum. The lower
amount of collagen synthesized by DS cultured alone, as compared to co-cultures, was repeatedly observed and may be related to the lower level












were detected, illustrating a high aminoprocollagen peptidase
activity. In DS/ADAMTS3-HEK293F cell co-culture, analysis of the
collagen pattern demonstrates a high aminoprocollagen peptidase
activity, although it is lower than that observed in presence of
ADAMTS2.
The same co-culture samples were investigated for type III
procollagen processing (Fig. 4E). A significant amount of fully
processed 1(III) was observed in the presence of ADAMTS2.
Procollagen III processing was also detected when DS were co-
cultured with cells expressing ADAMTS3.
Adamts3 is expressed at extraskeletal locations
Col2a1 expression has been previously reported at locations that
are not associated with cartilage formation (Cheah et al., 1991).
We found Adamts3 to be precisely co-expressed with Col2a1 at
one such location in the hindbrain at 12.5 dpc (Fig. 5A). In
addition, Adamts3 was highly expressed at other locations where
Col2a1, Col1a1 or Col3a1 gene expression was absent. At 15.5
dpc, Adamts3 was highly expressed in the developing cerebral
cortex (Fig. 5B), and at 17.5 dpc it was strongly expressed in the
subcommisural organ, a specialized ependymal zone between the
third and fourth ventricles (Fig. 5C), and in dorsal root ganglia
(Fig. 5D). We have not investigated Adamts3 expression in the
vitreous humor, another extraskeletal site of Col2a1 expression.
Adamts3 expression was seen in the wall of the urinary bladder
(Fig. 5E).
Adamts2, but not Adamts3 or Adamts14, is co-
expressed with Col3a1
Adamts2 was co-expressed with Col3a1 in the wall of large
arteries, such as the aorta, carotid and pulmonary arteries,
throughout mouse embryogenesis (Fig. 6A,B). By contrast,
Col1a1 was expressed only in the adventitial (outermost) layer of
arteries (data not shown). Expression of both Col3a1 and Adamts2
was highest in the lung mesenchyme (Fig. 6B,C). Adamts2 was
also co-expressed with Col3a1 at other sites, such as the palate
(Fig. 6D), the intestinal wall, peritoneum and mesentery (Fig. 6E),
the wall of the urinary bladder (Fig. 6F) and the skin (see Fig. 8A).
Adamts14 showed no co-expression with Col3a1, although
expression of Adamts3 in the wall of the urinary bladder partially
overlapped with the expression of both Adamts2 and Col3a1 (Fig.
5E, Fig. 6F). With this exception, Adamts3 was not otherwise co-
expressed with Col3a1.
Procollagen III processing is decreased in
Adamts2–/– mice
As only Adamts2 was substantially co-expressed with Col3a1, and
because ADAMTS2 processes procollagen III, we investigated
whether procollagen III processing was affected in Adamts2–/–
mice. Collagens were extracted from various mouse organs and
western blotting was used to evaluate procollagen III processing.
The different types of extraction gave essentially similar results. In
all cases, a substantial proportion of procollagen III was
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Fig. 5. Expression of Adamts3 outside the
musculoskeletal system. Hoechst 33258-stained images
are shown in the right-hand panel. (A) Co-expression of
Adamts3 and Col2a1 in the ﬂoor of the fourth ventricle in
the hindbrain (arrow). (B) Expression of Adamts3 in the
cerebral cortex. (C) Adamts3 expression in the ependyma
of the subcommissural organ. III, third ventricle.
(D) Adamts3 in dorsal root ganglia (drg). Note the sparse
expression in the vertebral cartilage (v) that comprises
mainly hypertrophic chondrocytes. (E) Expression of
Adamts3 in the inner musculature of the urinary bladder.
Note, in B-E, Adamts3 was not co-expressed with Col2a1.











unprocessed in the Adamts2–/– mice, whereas it was extensively or
completely processed in wild-type mice (Fig. 6G). To investigate
whether procollagen III processing by Adamts2 occurred in
inflammation-induced fibrosis, proteins were analyzed from
granulomas induced in Adamts2–/– and wild-type mice by
subcutaneous implantation of a PVA sponge. The analysis
demonstrated that most of the newly synthesized procollagen III
induced in the granulomas of wild-type mice was processed,
whereas little or no procollagen III processing occurred in the
granulomas induced in Adamts2–/– mice (Fig. 6H).
Adamts2–/– mice have distal airspace distension
The lung was the most prominent site of developmental expression
of Adamts2, where its distribution corresponded with that of Col3a1
(Fig. 6B,C). Lungs from two-month-old Adamts2–/– mice and wild-
type littermates were evaluated histologically after fixation under
inflation to optimize parenchymal distension. Adamts2–/– lungs had
a consistent decrease in parenchymal density at both 2 months (Fig.
7A) and 2 weeks (data not shown). This emphysema-like appearance
was unaccompanied by inflammatory cells or obvious fibrosis.
Histochemical detection of elastin and collagen (data not shown) did
not reveal any abnormalities and the ultrastructure showed the
presence of normal basement membranes (Fig. 7B), elastic fibers
and surfactant-producing pneumocytes (data not shown). By
contrast, the histology (Fig. 7C) and electron microscopy of the aorta
from Adamts2–/– mice did not show consistent changes from that of
the wild-type littermates. In both the lung and aorta (Fig. 7D) of
Adamts2–/– mice, the shape and diameter of collagen fibrils appeared
to be unaffected.
We investigated whether the processing of both procollagen I and
procollagen III were impaired in the aorta and lungs from
Adamts2–/– mice. Although it is not possible to comment from this
data on the relative proportion of the two collagens in these tissues,
it is clear that both newborn and adult Adamts2–/– mice demonstrated
significantly less processing of both collagens than did their wild-
type littermates (Fig. 7E,F).
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Fig. 6. Co-expression of Adamts2 and Col3a1, and deﬁciency of procollagen III processing in Adamts2–/– mice. (A,B) Adamts2 is co-
expressed with Col3a1 in the arterial wall, as shown at two developmental stages: 12.5 dpc carotid artery (A) and 17.5 dpc pulmonary artery (B). L,
lung. (C) Expression of Col3a1 and Adamts2 in lung. Note the expression in lung mesnchyme but not in the epithelium of bronchial tubes (asterisk).
(D) Co-expression of Adamts2 and Col3a1 in the mesenchyme of the palate (P). Adamts2 is also expressed in the perichondrium of the
basisphenoid (BS), at which location Col3a1 is absent. (E) Co-expression of Adamts2 and Col3a1 in the peritoneum lining the liver (L, arrow), and
mesentery of the gut (G) and pancreas (Pa). (F) Co-expression of Adamts2 and Col3a1 within the subepithelial layer of the developing urinary
bladder. Scale bar: 100 m. In D-F, Adamts2 expression is weaker than in lung and arteries, and Col3a1 expression is also signiﬁcantly weaker and
more dispersed. (G) Defective procollagen III processing in tissues from Adamts2–/– mice. Western blot analysis of procollagen isolated from mouse
tissues with 0.15 M NaCl is shown. The tissue origin of the sample and the respective genotype is shown above each lane; procollagen III and
collagen III molecular species are indicated on the left. Scanning densitometry of the different collagen III signals was used to calculate the
proportion of fully processed molecules in the various tissues (lower panel). (H) Defective procollagen III processing in newly synthesized collagen in
Adamts2–/– mice. Protein was extracted from sponge granulomas and western blotting used to deﬁne the molecular species of procollagen III that












Adamts2 and Adamts14 are co-expressed in
mature mouse dermis
In embryonic skin, low-level Adamts2 expression was noted, but no
expression of Adamts3 or Adamts14 was detected (Fig. 8A).
However, in two-week old mice, both Adamts2 and Adamts14 were
detected in the dermis, but not Adamts3 (Fig. 8B).
DISCUSSION
To rigorously establish the physiological significance of a protease-
substrate interaction in vivo requires that the protease and substrate
should be co-expressed, or that they should co-localize in tissues,
and that in the absence of the protease, cleavage of the substrate
should be reduced or absent. In addition, failure to cleave the
substrate should have a significant impact on a biological system.
We applied these criteria to exploring the roles of the procollagen N-
proteinases during mouse embryogenesis. The results suggest that
ADAMTS2 is the major procollagen III amino-propeptidase in
mice, but that it appears to share the procollagen I processing
function with ADAMTS3. Previous literature had suggested that a
significant proportion of procollagen III in tissues was unprocessed
and that the procollagen III-processing enzyme was not the same
enzyme that processed procollagen I (Halila and Peltonen, 1986;
Halila et al., 1986; Peltonen et al., 1985; Tuderman and Prockop,
1982). Wang et al. recently demonstrated that ADAMTS2 could
process procollagen III in vitro, but the in vivo relevance was unclear
(Wang et al., 2003). The overlapping expression of Adamts2 and
Col3a1, and the substantial reduction in procollagen III processing
in Adamts2–/– mice provides solid proof that ADAMTS2 is the major
procollagen III-processing enzyme.
The role of ADAMTS2 in processing procollagen III may further
contribute to the loss of mechanical integrity of dermatosparactic
skin, as collagen I and III are both present in the dermis. In situ
hybridization revealed prominent Col3a1 expression during lung
development, in accordance with a previous study suggesting that, in
mice, collagen III is a crucial structural component of the lung
(Shiomi et al., 2003). The pseudo-emphysematous appearance of the
lungs and the near-total lack of lung procollagen III processing in
Adamts2–/– mice strongly suggests a vital requirement for collagen
III in the lung. Lung abnormalities may result from a fragility of the
pulmonary walls, similar to skin fragility in dermatosparaxis. Neither
Adamts3 nor Adamts14 were expressed in the lung and, therefore,
there was no compensating processing enzyme. However, in the
aorta, which is severely affected by structural collagen III mutations,
the near-total lack of procollagen III processing had no apparent
effect on histology and collagen ultrastructure at 2 months of age. It
is possible that changes may be seen in older mice, or by the
induction of stress on the aortic wall in appropriate in vivo models.
The data suggest that ADAMTS3 probably makes a significant
contribution to procollagen I processing during musculoskeletal
development in mice. Expression of Adamts3 in many Col1a1-
RESEARCH ARTICLE Development 133 (8)
Fig. 7. Histology and ultrastructure of lung and aorta in Adamts2–/– mice and wild-type (+/+) littermates. (A) Comparative lung histology
from Adamts2–/– and their wild-type (+/+) littermates. The distal air spaces are much larger in the mutant mice, but there is no inﬂammatory
exudate. (B) Ultrastructure of an alveolar wall, demonstrating comparable basement membranes (arrows) in Adamts2–/– and wild-type mice. E,
erythrocyte. (C) Methylene blue-azure B stain for elastin in Adamts2–/– and wild-type aortas demonstrates comparable aortic wall thickness and
elastin lamellae (arrow). (D) Electron micrograph of collagen ﬁbrils in cross section (in area marked by the asterisk) demonstrates comparable size
and shape, and uniformity of ﬁbril diameter. Scale bar: 100 m in A,C; 500 nm in B,D. (E) Western blot analysis of procollagen III (above) and I
(below) processing in mouse lungs. Samples from wild-type and mutant newborn and adult mice are illustrated. (F) Western blot analysis of











expressing tissues, such as bone and tendon, may explain why the
most severe deficiencies in procollagen I processing in mouse
dermatosparaxis are in the dermis. Together with our previous
analysis of bovine dermatosparactic cartilage that demonstrated
complete procollagen II processing, the data suggest that
ADAMTS3 is probably the major procollagen II-processing
enzyme, and predict that Adamts3 mutations will lead to a
chondrodysplasia or osteochondrodysplasia. Although Col2a1 and
Col1a1 expression are generally mutually exclusive in tissues,
Adamts3 expression overlapped with that of both collagen genes.
Although we detected Adamts14 mRNA by RT-PCR of total embryo
RNA (data not shown), in situ hybridization with three non-
overlapping riboprobes showed no discernible developmental
expression.
Is it possible that the PNPs have substrates other than the fibrillar
procollagens? Although Adamts2 expression was associated with
procollagen gene expression, we noted strong expression of
Adamts3 in the nervous system at locations that lacked procollagen
I, II or III mRNA. For instance, Adamts3 was highly expressed in the
sub-commisural organ (SCO), a specialized ependymal organ
located at the entrance to the aqueduct of Sylvius. Its major secretory
product is SCO-spondin, a glycoprotein that undergoes proteolytic
processing prior to polymerization into the Reissner fiber of the
spinal cord (Gobron et al., 1996). It is possible that ADAMTS3
might also be a SCO-spondin-processing enzyme.
Can the major fibrillar procollagen amino-propeptides be
processed by other proteases? The highly conserved PNP modular
organization (except for the variable C-terminal module) is different
from all other proteases and is probably highly specialized for
binding to triple-helical collagens. Heat-denatured collagen is not
efficiently processed by ADAMTS2 (Tuderman et al., 1978),
suggesting a need for spatially stringent interactions between the
ancillary domain and the triple helix. Because residual procollagen
processing in dermatosparactic skin occurs at the same cleavage site
as in normal skin (Colige et al., 2002), it supports processing by an
enzyme(s) closely related to ADAMTS2. It is clear from the
Adamts2–/– mice that absence of ADAMTS2 leads to a significant
loss of processing of procollagen III in many tissues. At these
locations, neither Adamts3 nor Adamts14 are expressed, and, thus,
do not compensate for its absence. Thus other enzymes do not
appear to compensate significantly. A splice variant of collagen II,
termed IIA is expressed in pre-cartilaginous mesenchyme and in
perichondrium (Ryan and Sandell, 1990; Ryan et al., 1990).
Ultrastructural and biochemical studies suggest its N-propeptide is
not excised during development, suggesting perhaps that it is
resistant to the action of these proteases (Zhu et al., 1999). By
contrast, matrix metalloproteinases (MMPs) have been shown to
cleave the propeptide from collagen IIA at numerous sites other than
the PNP bond (Fukui et al., 2002).
ADAMTS2 mutations in humans lead to characteristic craniofacial
changes and decreased growth; features that are absent in Adamts2–/–
mice. As individuals with EDS-VIIC age, the skin fragility is
somewhat ameliorated and there is increasing joint laxity, which is
not a prominent feature in early childhood. Adamts2–/– mice also
have fragile skin, but they are not significantly growth retarded and
have no craniofacial dysmorphism (Li et al., 2001). These
differences between EDS-VIIC and mouse dermatosparaxis are
compatible with the different deployment of functionally equivalent
enzymes in humans and mice through the transcriptional regulation
of their genes. The expression of ADAMTS3 and ADAMTS14 may
change with age in humans, perhaps explaining how the properties
of dermatosparactic skin change as affected individuals get older.
In addition to skin fragility, humans with EDS-VIIC manifest
with a variety of other anomalies. Easy bruising, a universal sign in
patients with EDS-VIIC, can be partly attributed to the ability of
ADAMTS2 to process procollagen III, and to our observation, albeit
in mice, that it is the only PNP expressed at significantly high levels
in the walls of blood vessels. The procollagen III-processing defect
in the absence of ADAMTS2 appears to be dramatic in most mouse
tissues. We were particularly concerned that procollagen III
processing in the mouse aorta was defective. Although histology and
electron microscopy did not reveal specific anomalies in the aortic
wall, and no aortic or other vascular aneurysms have been hitherto
noted in EDS-VIIC patients, our findings suggest a need for the
monitoring of EDS-VIIC patients as they age. Bladder rupture and
intestinal perforations have been reported in individuals with EDS-
VIIC. Our studies demonstrate co-expression of procollagen III and
ADAMTS2 in the developing mouse at these locations. A recent
clinical study emphasized the abnormal permanent dentition of
individuals with EDS-VIIC, including hypodontia (De Coster et al.,
2003). Adamts2–/– mice have mild dental changes and compensation
by Adamts3 may account for this.
Most of the 19 ADAMTS proteases can be assigned to
phylogenetically distinct clades (Apte, 2004; Huxley-Jones et al.,
2005; Nicholson et al., 2005). Recent analysis of ADAMTS gene
evolution suggests that genes within mammalian ADAMTS clades
arose by duplication of their primitive ancestors (Huxley-Jones et
al., 2005; Nicholson et al., 2005). We speculated that, following
duplication, closely related genes, such as ADAMTS2, ADAMTS3
and ADAMTS14, were highly conserved to provide
subfunctionalization (retention of molecular function but with
diversification of expression patterns) rather than
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Fig. 8. Procollagen N-propeptidase expression in
skin. D, dermis; the white dashed line indicates the line of
demarcation of epidermis and dermis. (A) Co-expression
of Col3a1 and Col1a1 in the dermis of the skin of a 17.5
dpc embryo. Adamts2, but not Adamts14 or Adamts3,
mRNA was detected in the dermis. (B) Adamts2 and
Adamts14 mRNA, but not Adamts3 mRNA, is detectable












neofunctionalization (acquisition of new functions) (Huxley-Jones
et al., 2005). The ability of all three PNPs to process procollagen I,
but specialization in this regard as a result of differential gene
regulation, supports this hypothesis. Other ADAMTS clades may
exhibit the same phenomenon.
We thank D. Prockop for Adamts2–/– mice; E. Vuorio, B. de Crombrugghe and
N. Fukai for cDNA probes; Amanda Allamong for histology; Katie Jungers for
assistance with in situ hybridization; Kaitlin Petrella for assistance with electron
microscopy; and Craig Bennetts for mCT scanning. The studies were supported
by grants from the National Institutes of Health (AR49590 to S.S.A. and
AR44745 to D.E.B.). A.C.C. is supported by the Belgian Fonds National de la
Recherche Scientiﬁque (grant 3.4562.03), and F.K. by a Télévie grant
(7.4.561.03.F). Histology and mCT was supported by a Core Center for
Musculoskeletal Disorders award from NIH (AR050953).
References
Apte, S. S. (2004). A disintegrin-like and metalloprotease (reprolysin type) with
thrombospondin type 1 motifs: the ADAMTS family. Int. J. Biochem. Cell Biol.
36, 981-985.
Birk, D. E. and Trelstad, R. L. (1986). Extracellular compartments in tendon
morphogenesis: collagen ﬁbril, bundle, and macroaggregate formation. J. Cell
Biol. 103, 231-240.
Birk, D. E., Silver, F. H. and Trelstad, R. L. (1991). Matrix Assembly. In Cell
Biology of Extracellular Matrix (ed. E. D. Hay), pp. 221-254. New York: Plenum
Press.
Canty, E. G., Lu, Y., Meadows, R. S., Shaw, M. K., Holmes, D. F. and Kadler,
K. E. (2004). Coalignment of plasma membrane channels and protrusions
(ﬁbripositors) speciﬁes the parallelism of tendon. J. Cell Biol. 165, 553-563.
Chan, D., Rogers, J. F., Bateman, J. F. and Cole, W. G. (1995). Recurrent
substitutions of arginine 789 by cysteine in pro-alpha 1 (II) collagen chains
produce spondyloepiphyseal dysplasia congenita. J. Rheumatol. Suppl. 43, 37-
38.
Cheah, K. S., Lau, E. T., Au, P. K. and Tam, P. P. (1991). Expression of the mouse
alpha 1(II) collagen gene is not restricted to cartilage during development.
Development 111, 945-953.
Cole, W. G. (1997). Abnormal skeletal growth in Kniest dysplasia caused by type II
collagen mutations. Clin. Orthop. Relat. Res. 341, 162-169.
Colige, A., Sieron, A. L., Li, S. W., Schwarze, U., Petty, E., Wertelecki, W.,
Wilcox, W., Krakow, D., Cohn, D. H., Reardon, W. et al. (1999). Human Ehlers-
Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations
in the procollagen I N-proteinase gene. Am. J. Hum. Genet. 65, 308-317.
Colige, A., Vandenberghe, I., Thiry, M., Lambert, C. A., Van Beeumen, J., Li,
S. W., Prockop, D. J., Lapiere, C. M. and Nusgens, B. V. (2002). Cloning and
characterization of ADAMTS-14, a novel ADAMTS displaying high homology
with ADAMTS-2 and ADAMTS-3. J. Biol. Chem. 277, 5756-5766.
Colige, A., Nuytinck, L., Hausser, I., Van Essen, A. J., Thiry, M., Herens, C.,
Ades, L. C., Malfait, F., Paepe, A. D., Franck, P. et al. (2004). Novel types of
mutation responsible for the dermatosparactic type of Ehlers-Danlos Syndrome
(Type VIIC) and common polymorphisms in the ADAMTS2 gene. J. Invest.
Dermatol. 123, 656-663.
De Coster, P. J., Malfait, F., Martens, L. C. and De Paepe, A. (2003). Unusual
oral ﬁndings in dermatosparaxis (Ehlers-Danlos syndrome type VIIC). J. Oral
Pathol. Med. 32, 568-570.
De Paepe, A. and Malfait, F. (2004). Bleeding and bruising in patients with
Ehlers-Danlos syndrome and other collagen vascular disorders. Br. J. Haematol.
127, 491-500.
Fernandes, R. J., Hirohata, S., Engle, J. M., Colige, A., Cohn, D. H., Eyre, D. R.
and Apte, S. S. (2001). Procollagen II amino propeptide processing by
ADAMTS-3. Insights on dermatosparaxis. J. Biol. Chem. 276, 31502-31509.
Fukui, N., McAlinden, A., Zhu, Y., Crouch, E., Broekelmann, T. J., Mecham, R.
P. and Sandell, L. J. (2002). Processing of type II procollagen amino propeptide
by matrix metalloproteinases. J. Biol. Chem. 277, 2193-2201.
Gobron, S., Monnerie, H., Meiniel, R., Creveaux, I., Lehmann, W., Lamalle,
D., Dastugue, B. and Meiniel, A. (1996). SCO-spondin: a new member of the
thrombospondin family secreted by the subcommissural organ is a candidate in
the modulation of neuronal aggregation. J. Cell Sci. 109, 1053-1061.
Halila, R. and Peltonen, L. (1986). Puriﬁcation of human procollagen type III N-
proteinase from placenta and preparation of antiserum. Biochem. J. 239, 47-52.
Halila, R., Steinmann, B. and Peltonen, L. (1986). Processing of types I and III
procollagen in Ehlers-Danlos syndrome type VII. Am. J. Hum. Genet. 39, 222-231.
Huxley-Jones, J., Apte, S. S., Robertson, D. L. and Boot-Handford, R. P.
(2005). The characterisation of six ADAMTS proteases in the basal chordate
Ciona intestinalis provides new insights into the vertebrate ADAMTS family. Int.
J. Biochem. Cell Biol. 37, 1838-1845.
Kessler, E., Takahara, K., Biniaminov, L., Brusel, M. and Greenspan, D. S.
(1996). Bone morphogenetic protein-1: the type I procollagen C-proteinase.
Science 271, 360-362.
Lapiere, C. M. and Nusgens, B. V. (1993). Ehlers-Danlos type VII-C, or human
dermatosparaxis. The offspring of a union between basic and clinical research.
Arch. Dermatol. 129, 1316-1319.
Li, S. W., Arita, M., Fertala, A., Bao, Y., Kopen, G. C., Langsjo, T. K., Hyttinen,
M. M., Helminen, H. J. and Prockop, D. J. (2001). Transgenic mice with
inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin
and male sterility. Biochem. J. 355, 271-278.
LuValle, P., Hayashi, M. and Olsen, B. R. (1989). Transcriptional regulation of
type X collagen during chondrocyte maturation. Dev. Biol. 133, 613-616.
Malfait, F., De Coster, P., Hausser, I., van Essen, A. J., Franck, P., Colige, A.,
Nusgens, B., Martens, L. and De Paepe, A. (2004). The natural history,
including orofacial features of three patients with Ehlers-Danlos syndrome,
dermatosparaxis type (EDS type VIIC). Am. J. Med. Genet. A 131, 18-28.
Nicholson, A. C., Malik, S. B., Logsdon, J. M., Jr and Van Meir, E. G. (2005).
Functional evolution of ADAMTS genes: evidence from analyses of phylogeny
and gene organization. BMC Evol. Biol. 5, 11.
Niederreither, K., D’Souza, R., Metsaranta, M., Eberspaecher, H., Toman, P.
D., Vuorio, E. and De Crombrugghe, B. (1995). Coordinate patterns of
expression of type I and III collagens during mouse development. Matrix Biol. 14,
705-713.
Nusgens, B. V., Verellen-Dumoulin, C., Hermanns-Le, T., De Paepe, A.,
Nuytinck, L., Pierard, G. E. and Lapiere, C. M. (1992). Evidence for a
relationship between Ehlers-Danlos type VII C in humans and bovine
dermatosparaxis. Nat. Genet. 1, 214-217.
Oblander, S. A., Zhou, Z., Galvez, B. G., Starcher, B., Shannon, J. M.,
Durbeej, M., Arroyo, A. G., Tryggvason, K. and Apte, S. S. (2005).
Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or
MMP-14) in lung and submandibular gland development are independent of its
role in pro-MMP-2 activation. Dev. Biol. 277, 255-269.
Olsen, B. R. (1991). Collagen Biosynthesis. In Cell Biology of Extracellular Matrix
(ed. E. D. Hay), pp. 177-220. New York: Plenum Press.
Peltonen, L., Halila, R. and Ryhanen, L. (1985). Enzymes converting
procollagens to collagens. J. Cell. Biochem. 28, 15-21.
Petty, E. M., Seashore, M. R., Braverman, I. M., Spiesel, S. Z., Smith, L. T. and
Milstone, L. M. (1993). Dermatosparaxis in children. A case report and review
of the newly recognized phenotype. Arch. Dermatol. 129, 1310-1315.
Rauch, F. and Glorieux, F. H. (2004). Osteogenesis imperfecta. Lancet 363, 1377-
1385.
Ryan, M. C. and Sandell, L. J. (1990). Differential expression of a cysteine-rich
domain in the amino-terminal propeptide of type II (cartilage) procollagen by
alternative splicing of mRNA. J. Biol. Chem. 265, 10334-10339.
Ryan, M. C., Sieraski, M. and Sandell, L. J. (1990). The human type II
procollagen gene: identiﬁcation of an additional protein-coding domain and
location of potential regulatory sequences in the promoter and ﬁrst intron.
Genomics 8, 41-48.
Shiomi, T., Okada, Y., Foronjy, R., Schiltz, J., Jaenish, R., Krane, S. and
D’Armiento, J. (2003). Emphysematous changes are caused by degradation
of type III collagen in transgenic mice expressing MMP-1. Exp. Lung Res. 29, 1-
15.
Smith, L. T., Wertelecki, W., Milstone, L. M., Petty, E. M., Seashore, M. R.,
Braverman, I. M., Jenkins, T. G. and Byers, P. H. (1992). Human
dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to
remove the amino-terminal propeptide of type I procollagen. Am. J. Hum.
Genet. 51, 235-244.
Snead, M. P. and Yates, J. R. (1999). Clinical and molecular genetics of Stickler
syndrome. J. Med. Genet. 36, 353-359.
Somerville, R. P., Longpre, J. M., Jungers, K. A., Engle, J. M., Ross, M.,
Evanko, S., Wight, T. N., Leduc, R. and Apte, S. S. (2003). Characterization
of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to
Caenorhabditis elegans GON-1. J. Biol. Chem. 278, 9503-9513.
Tiller, G. E., Polumbo, P. A., Weis, M. A., Bogaert, R., Lachman, R. S., Cohn,
D. H., Rimoin, D. L. and Eyre, D. R. (1995). Dominant mutations in the type II
collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick
type. Nat. Genet. 11, 87-89.
Tuderman, L. and Prockop, D. J. (1982). Procollagen N-proteinase. Properties of
the enzyme puriﬁed from chick embryo tendons. Eur. J. Biochem. 125, 545-
549.
Tuderman, L., Kivirikko, K. I. and Prockop, D. J. (1978). Partial puriﬁcation and
characterization of a neutral protease which cleaves the N-terminal propeptides
from procollagen. Biochemistry 17, 2948-2954.
Wang, W. M., Lee, S., Steiglitz, B. M., Scott, I. C., Lebares, C. C., Allen, M. L.,
Brenner, M. C., Takahara, K. and Greenspan, D. S. (2003). Transforming
growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III
N-proteinase. J. Biol. Chem. 278, 19549-19557.
Wertelecki, W., Smith, L. T. and Byers, P. (1992). Initial observations of human
dermatosparaxis: Ehlers-Danlos syndrome type VIIC. J. Pediatr. 121, 558-564.
Zhu, Y., Oganesian, A., Keene, D. R. and Sandell, L. J. (1999). Type IIA
procollagen containing the cysteine-rich amino propeptide is deposited in the
extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-
2. J. Cell Biol. 144, 1069-1080.
RESEARCH ARTICLE Development 133 (8)
